Sumitomo Mitsui Trust Group Inc. Has $20.64 Million Holdings in Avantor, Inc. $AVTR

Sumitomo Mitsui Trust Group Inc. lessened its holdings in Avantor, Inc. (NYSE:AVTR) by 0.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,533,172 shares of the company’s stock after selling 11,262 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.22% of Avantor worth $20,636,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in AVTR. 1832 Asset Management L.P. raised its holdings in shares of Avantor by 89.8% in the 1st quarter. 1832 Asset Management L.P. now owns 18,127,204 shares of the company’s stock worth $293,842,000 after acquiring an additional 8,578,493 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in Avantor by 53.2% in the 1st quarter. The Manufacturers Life Insurance Company now owns 14,034,699 shares of the company’s stock valued at $227,502,000 after buying an additional 4,876,524 shares during the last quarter. Invesco Ltd. increased its stake in Avantor by 19.3% in the 1st quarter. Invesco Ltd. now owns 11,669,411 shares of the company’s stock valued at $189,161,000 after buying an additional 1,884,273 shares during the last quarter. Clarkston Capital Partners LLC increased its stake in Avantor by 17.8% in the 1st quarter. Clarkston Capital Partners LLC now owns 9,591,950 shares of the company’s stock valued at $155,486,000 after buying an additional 1,446,125 shares during the last quarter. Finally, Alliancebernstein L.P. raised its position in shares of Avantor by 28.0% during the 1st quarter. Alliancebernstein L.P. now owns 6,262,052 shares of the company’s stock valued at $101,508,000 after buying an additional 1,370,577 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 3,476 shares of the business’s stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total transaction of $39,591.64. Following the sale, the chief accounting officer owned 55,068 shares of the company’s stock, valued at $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.20% of the stock is owned by insiders.

Avantor Price Performance

Shares of Avantor stock opened at $11.57 on Thursday. The firm has a market cap of $7.88 billion, a PE ratio of 11.68, a price-to-earnings-growth ratio of 4.92 and a beta of 0.98. Avantor, Inc. has a 12-month low of $10.82 and a 12-month high of $23.70. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. The company’s fifty day simple moving average is $13.39 and its two-hundred day simple moving average is $13.31.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The firm had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.65 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.Avantor’s revenue was down 5.3% on a year-over-year basis. During the same period last year, the business earned $0.26 EPS. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. As a group, equities analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analysts Forecast Growth

AVTR has been the topic of several research reports. Evercore ISI lowered their price objective on shares of Avantor from $18.00 to $16.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Barclays lifted their target price on shares of Avantor from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Wells Fargo & Company decreased their target price on shares of Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Stifel Nicolaus set a $12.00 target price on shares of Avantor and gave the stock a “hold” rating in a research report on Monday, August 4th. Finally, Raymond James Financial lifted their target price on shares of Avantor from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Seven analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $15.96.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.